Evidence map›Paper›PMID 33004515›Full record

ArticleScience (New York, N.Y.)2020

Macroscopic somatic clonal expansion in morphologically normal human urothelium.

Ruoyan Li, Yiqing Du, Zhanghua Chen, Deshu Xu, Tianxin Lin, Shanzhao Jin, Gongwei Wang, Ziyang Liu, Min Lu, Xu Chen and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Science (New York, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed, 1 pooled it
30.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 1 synthesis or guideline pooled it, 212 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Single-Cell Low-Pass Whole Genome Sequencing of Circulating Tumor Cells.Methods in molecular biology (Clifton, N.J.) · 2026
    Article
  20. Article

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Ruoyan Li *Biomedical Pioneering Innovation Center (BIOPIC), School of Life Sciences, Peking University, Beijing, China.ORCID 0000-0001-5337-9729
Yiqing Du *Department of Urology, Peking University People's Hospital, Beijing, China.ORCID 0000-0002-5089-727X
Zhanghua Chen *Biomedical Pioneering Innovation Center (BIOPIC), School of Life Sciences, Peking University, Beijing, China.ORCID 0000-0002-2505-0675
Deshu Xu *Biomedical Pioneering Innovation Center (BIOPIC), School of Life Sciences, Peking University, Beijing, China.ORCID 0000-0001-9647-9826
Tianxin Lin *Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.ORCID 0000-0003-3180-8697
Shanzhao JinBiomedical Pioneering Innovation Center (BIOPIC), School of Life Sciences, Peking University, Beijing, China.ORCID 0000-0003-3939-4978
Gongwei WangDepartment of Pathology, Peking University People's Hospital, Beijing, China.
Ziyang LiuBiomedical Pioneering Innovation Center (BIOPIC), School of Life Sciences, Peking University, Beijing, China.ORCID 0000-0002-3067-9523
Min LuDepartment of Pathology, School of Basic Medical Sciences, Peking University Third Hospital, Peking University Health Science Center, Beijing, China.
Xu ChenDepartment of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China.ORCID 0000-0002-8425-036X
Tao XuDepartment of Urology, Peking University People's Hospital, Beijing, China. xutao@pkuph.edu.cn fbai@pku.edu.cn.ORCID 0000-0003-3899-1500
Fan BaiBiomedical Pioneering Innovation Center (BIOPIC), School of Life Sciences, Peking University, Beijing, China. xutao@pkuph.edu.cn fbai@pku.edu.cn.ORCID 0000-0001-6119-8936
Peking University · CNSun Yat-sen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Knowledge of somatic mutation accumulation in normal cells, which is essential for understanding cancer development and evolution, remains largely lacking. In this study, we investigated somatic clonal events in morphologically normal human urothelium (MNU; epithelium lining the bladder and ureter) and identified macroscopic clonal expansions. Aristolochic acid (AA), a natural herb-derived compound, was a major mutagenic driving factor in MNU. AA drastically accelerates mutation accumulation and enhances clonal expansion. Mutations in MNU were widely observed in chromatin remodeling genes such as

Indexed as

Aristolochic AcidsChromatin Assembly and DisassemblyClass I Phosphatidylinositol 3-KinasesDNA-Binding ProteinsHistone DemethylasesHumansMutagenesisMutagensMutationNeoplasm ProteinsReceptor, Fibroblast Growth Factor, Type 3Tumor Suppressor Protein p53Urinary Bladder NeoplasmsUrotheliumaristolochic acid IAristolochic AcidsClass I Phosphatidylinositol 3-KinasesDNA-Binding ProteinsFGFR3 protein, humanHistone DemethylasesKDM6A protein, humanKMT2D protein, humanMutagensNeoplasm ProteinsPIK3CA protein, humanReceptor, Fibroblast Growth Factor, Type 3TP53 protein, humanTumor Suppressor Protein p53

Identifiers

PMID33004515
OpenAlexW3091186260

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.